SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

In conclusion, individual ambulatory care expenditures are substantially higher among patients with T2DM in a stable treatment phase ... Pharmacy is the first category of ambulatory care ...